Wegovy — Lose Up to 20.7% of Your Body Weight

The first GLP-1 weight loss treatment with proven heart health benefits. Prescribed by our independent pharmacist.

GPhC Registered Pharmacy
MHRA Licensed
UK Independent Prescriber
Discreet Packaging

How This Medication Works

GLP-1 Receptor Action

Semaglutide activates GLP-1 receptors in the brain, decreasing hunger and increasing fullness. You naturally eat less without feeling deprived.

Proven Heart Health Benefits

The SELECT trial showed Wegovy reduces major cardiovascular events by 20%. This protection extends to people without diabetes, a major breakthrough in weight loss medicine.

Sustained, Gentle Weight Loss

Weekly injections provide steady medication levels with a slower, gentler dose escalation. Most people see results within 2 to 4 weeks.

Clinical Evidence

STEP UP Trial

Participants treated with Wegovy lost an average of 20.7% of their body weight over 72 weeks at the highest dose (2.4mg).

SELECT Trial — Cardiovascular Benefits

In adults with obesity or overweight with cardiovascular disease, Wegovy reduced the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) by 20%. This demonstrated that weight loss with semaglutide offers protection beyond the scale.

These results represent average outcomes. Individual results may vary. Always discuss expected outcomes with your prescriber before starting treatment.

Dose Escalation Schedule

Weeks 1–4

0.25mg once weekly
Your starting dose. Gentle introduction to minimise initial side effects.

Weeks 5–8

0.5mg once weekly
First escalation. Side effects typically improve as your body adapts.

Weeks 9–12

1mg once weekly
Mid-range dose. Most people see noticeable weight loss starting here.

Weeks 13–16

1.7mg once weekly
Higher therapeutic dose with stronger appetite suppression.

Week 17 Onwards

2.4mg once weekly (maintenance)
Maximum dose. Continue indefinitely or as prescribed by your pharmacist. Injected subcutaneously (under the skin).

Pricing

Dose Strength Monthly Price
0.25mg £99.99
0.5mg £99.99
1mg £119.99
1.7mg £149.99
2.4mg (maintenance) £179.99
Prices are placeholders and will be confirmed before launch.

Side Effects

Common Side Effects

  • Nausea
  • Diarrhoea
  • Vomiting
  • Constipation
  • Headache
What to know: Most side effects are mild and improve within the first few weeks as your body adapts. The gentler dose escalation with Wegovy (compared to other GLP-1 treatments) means many patients tolerate it very well. Nausea, when it occurs, typically resolves by week 4–6. Headache is usually mild and manageable.

Who Is It Suitable For

BMI Requirements

BMI of 30 or higher, or BMI of 27 or higher if you have a weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol.

Age

You must be 18 years or older to take Wegovy for weight loss.

Cardiovascular Health

Wegovy is especially beneficial if you have cardiovascular risk factors or existing heart disease, as it has demonstrated heart-protective benefits in clinical trials.

Medical Exclusions

Wegovy is not suitable if you have a personal or family history of medullary thyroid cancer, severe kidney disease, or any contraindications. Tell your pharmacist about all health conditions before starting.

Frequently Asked Questions

How do I inject Wegovy?

+
Wegovy is a subcutaneous injection administered once weekly. You inject it into your abdomen, thigh, or upper arm. The injection is simple and painless, using a very small needle. A typical injection takes less than 10 seconds. We provide detailed instructions and support to help you feel confident using it.

What if I miss a dose?

+
If you miss your weekly injection by 2 days or less, inject as soon as you remember. If more than 2 days have passed, skip that dose and continue your normal weekly schedule. Never inject a double dose to catch up. Contact your pharmacist if you have questions about a missed dose.

Can I drink alcohol on Wegovy?

+
Moderate alcohol consumption is generally acceptable on Wegovy. However, alcohol can worsen nausea and may affect blood sugar, particularly if you have diabetes. Limit your intake and always drink with food. Avoid binge drinking. Discuss your alcohol use with your pharmacist if you have health concerns.

How is Wegovy different from Mounjaro?

+
Wegovy contains semaglutide (a single GLP-1 receptor agonist) whilst Mounjaro contains tirzepatide (a dual GLP-1 and GIP receptor agonist). Mounjaro produces slightly greater weight loss (22.5% vs. 20.7%) but has a steeper dose escalation. Wegovy has proven cardiovascular benefits and a gentler escalation schedule, making it ideal for cardiovascular-conscious patients. Both are highly effective; choice depends on your medical profile and preferences.

Is Wegovy the same as Ozempic?

+
Both Wegovy and Ozempic contain semaglutide, but they are different medications. Ozempic is approved for type 2 diabetes management and uses a lower dose range (up to 1mg). Wegovy is specifically approved for weight loss and uses higher doses (up to 2.4mg). The dose, monitoring, and clinical indication are different, so they are not interchangeable.

When will I start seeing results?

+
You will typically notice reduced appetite within 1 to 2 weeks. Visible weight loss usually begins within 2 to 4 weeks, with significant progress by 8 to 12 weeks. Results continue improving as you escalate the dose and your body adjusts. Maximum weight loss generally occurs around 16 to 20 weeks of treatment.

Check Your Eligibility for Wegovy

Ready to lose up to 20.7% of your body weight with heart health benefits? Our independent pharmacist will assess your eligibility for Wegovy.